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Mutations in with-no-lysine (K) kinase 4 (WNK4) and a ubiquitin E3 ligase complex component kel-
ch-like 3 (KLHL3) both cause pseudohypoaldosteronism II (PHAII), a hereditary form of hyperten-
sion. We determined whether WNK4 or its effector is regulated by KLHL3 in Xenopus oocytes.
KLHL3 inhibited the positive effect of WNK4 on Na+–Cl cotransporter (NCC) by decreasing WNK4
protein abundance without decreasing that of NCC and the downstream kinase OSR1 directly. Ubiq-
uitination and degradation of WNK4 were induced by KLHL3. The effect of KLHL3 on WNK4 degra-
dation was blocked by a dominant negative form of cullin 3. All ﬁve PHAII mutations of KLHL3 tested
disrupted the regulation on WNK4. We conclude that KLHL3 is a substrate adaptor for WNK4 in a
ubiquitin E3 ligase complex.
Structured summary of protein interactions:
CUL3 physically interacts with KLHL3 by pull down (View interaction)
WNK4 physically interacts with KLHL3 by pull down (View interaction)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Pseudohypoaldosteronism II (PHAII), also known as familial
hyperkalemia and hypertension or Gordon’s syndrome, is a Mende-
lian form of hypertension with hyperkalemia, mild metabolic aci-
dosis, and low plasma renin [1,2]. In 2001, mutations in WNK1
and WNK4, two genes of with-no-lysine (K) (WNK) serine/threo-
nine kinase family, were identiﬁed to be associated with PHAII
[3]. Among the two genes, WNK4 harbors missense mutations that
may alter the function/regulation of WNK4 protein [3]. Indeed,
PHAII mutations in the acidic motif alter Ca2+-sensitivity of
WNK4 kinase [4]. The R1185C mutation, on the other hand, resides
inside a calmodulin binding domain in the vicinity of three phos-
phorylation sites for the serum- and glucocorticoid-induced pro-
tein kinase 1 (SGK1) [5–7]. The calmodulin binding and SGK1
phosphorylation sites are parts of a regulatory domain that inhibits
WNK4 activity, and the R1185C mutation alleviates the inhibitory
effect [5]. WNK4 is an integrative regulator of renal electrolytetransport with the thiazide-sensitive Na+–Cl cotransporter (NCC)
as the main target [8–10]. The effects of WNK4 on NCC are
complex: on the one hand, WNK4 inhibits NCC and increases its
lysosomal degradation [11–14]; on the other, NCC is stimulated
by WNK4 via proline–alanine-rich STE20-related kinase (SPAK)
and oxidative stress-responsive 1 (OSR1) in a phosphorylation cas-
cade [10,15,16]. Furthermore, in the presence of angiotensin II, the
positive effect overtakes the inhibitory effect of WNK4 in a SPAK-
dependent manner [17]. The PHAII-causing WNK4 mutants up-
regulate NCC as if WNK4 is activated by angiotensin II [17]. Thus,
PHAII mutations likely disrupt the Ca2+-dependent activation
mechanism of WNK4 and lock WNK4 at a state equivalent to that
stimulated by the renin–angiotensin–aldosterone system [4,5].
A decade after the identiﬁcation of the association ofWNK1 and
WNK4 mutations with PHAII, mutations in two genes of a likely
cullin-RING ubiquitin E3 ligase complex, kelch-like 3 (KLHL3) and
cullin 3 (CUL3) were also identiﬁed to cause PHAII [18,19]. CUL3
is a scaffold protein that connects the substrate adaptor protein
and RING-box 1 ubiquitin ligase E3 in the cullin-RING ubiquitin
E3 ligase complexes [20]. Members of the kelch-like family were
shown to serve as substrate adaptors in these complexes [21,22].
Thus, it is likely that KLHL3 and CUL3 are part of a cullin-RING
ubiquitin E3 ligase complex that speciﬁcally targets renal electro-
lyte transporters or their regulators involved in Na+ and/or K+
transport. While CUL3 is ubiquitously expressed in the kidney,
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WNK4 and NCC are expressed [18,19]. KLHL3 decreases NCC plas-
ma membrane abundance when they were co-transfected into
cells [19]. It is unclear, however, which step of the regulation cas-
cade is the target of the ubiquitin E3 ligase complex containing
KLHL3.
In this study, we provide evidence that WNK4, rather than the
downstream targets of WNK4, is a substrate of the E3 ligase com-
plex containing KLHL3. PHAII mutations in KLHL3 may lead to ele-
vated WNK4 protein abundance and therefore elevated WNK4
activity, leading to disease.
2. Materials and methods
2.1. cDNA constructs
The human WNK4 cDNA was a generous gift from Dr. Xavier
Jeunemaitre and was used previously [4,5,23]. The cDNA for mouse
NCC (BC038612) [4] was purchased from Open Biosystems
(Huntsville, AL). The human OSR1 and KLHL3 cDNAs were cloned
from HEK-293 cells and human CUL3 cDNA was cloned from
SW480 cells using reverse transcription PCR approach. These cDNAs
were subcloned into Xenopus laevis (X. laevis) oocytes expression
vector pIN and their sequences were veriﬁed by sequencing. FLAG,
HA, or GST tag was added to NH2-termini of the cDNAs for detecting
protein expression or for GST pull-down experiments. The PHAII
mutations in KLHL3 were generated using QuikChange II site-
directed mutagenesis kit (Stratagene, La Jolla, CA).
2.2. Western blot analysis
Western blot analyses were performed as described previously
[23]. Lysates from ten oocytes were extracted in each group. Mono-
clonal anti-HA antibody (product # H9658, 1:5000 dilution) and
anti-FLAG antibody (F7425, 1:2000 dilution) were purchased from
Sigma–Aldrich (St. Louis, MO). Anti-GST (27-4577-01, 1:2000) was
purchased from GE Healthcare Life Sciences (Piscataway, NJ). Anti-
body speciﬁc for phosphorylated serine 325 of OSR1 was pur-
chased from EMD Millipore (product # 07-2273, Billerica, MA).
The anti-b-actin antibody (sc-47778, 1:5000) was purchased from
Santa Cruz Biotechnology (Santa Cruz, CA). Appropriate horserad-
ish peroxidase (HRP)-conjugated secondary antibodies (1:5000
dilution) were purchased from Santa Cruz Biotechnology. Chemilu-
minescence signals were detected using SuperSignal West Femto
Maximum Sensitivity Substrate kit or SuperSignal West Pico
Chemiluminescent Substrate kit (Pierce Biotechnology, Rockford,
IL).
2.3. GST pull-down assay
X. laevis oocytes were injected with cRNAs encoding GST (as
control), GST–WNK4, GST–CUL3, or HA-KLHL3 and were cultured
in 0.5 L-15 medium at 18 C. 2 days after injection, 50 oocytes
were lysed with lysis buffer (NaCl 100 mM, TrisCl 20 mM, Triton
X100 1%, plus protease inhibitor cocktail, pH 7.6) at 20 ll/oocyte.
After vigorous vortex, the oocytes were centrifuged at 3500g
for 10 min at 4 C to remove the cellular debris and yolk proteins.
The supernatant of protein extract from GST or GST–WNK4 group
was incubated with 50 ll slurry glutathione Sepharose (GE Health-
care, Piscataway, NJ) for 2 h at room temperature. The Sepharose
beads were washed 3 times with 500 ll lysis buffer, and then were
incubated with 600 ll lysate from oocytes expressing HA-KLHL3.
After rocking at 4 C overnight, the Sepharose beads were washed
3 times again with 500 ll lysis buffer supplemented with protease
inhibitor cocktail. Then GST, GST–CUL3, or GST–WNK4 and pro-
teins associated with them were eluted from Sepharose beads byincubation with 10 mM L-glutathione reduced for 1 h at 4 C. Both
the supernatants and the proteins bound to the Sepharose beads
were respectively subjected to SDS–PAGE. The proteins were trans-
ferred from the SDS–PAGE to PVDF membrane and immunoblot-
ting experiments were carried out with anti-GST (27-4577-01,
GE healthcare, 1:2000 dilution) and anti-HA (H9658, Sigma–Al-
drich, 1:5000 dilution) antibodies to determine whether HA-KLHL3
was associated with GST-fusion proteins.
2.4. Na+ uptake assay
X. laevis oocytes were used for Na+ uptake assay. The animal
protocol used in this study was approved by the Institutional Ani-
mal Care and Use Committee (IACUC) of the University of Alabama
at Birmingham. X. laevis oocytes were collected and cultured in
0.5 L-15 medium as previously described [23,24]. Oocytes were
microinjected with in vitro transcribed capped complementary
RNAs (cRNAs) of untagged, HA or FLAG tagged NCC, WNK4, KLHL3,
CUL3 at 6.25–12.5 ng/oocyte. When two or three cRNAs were co-
injected, the total amount of cRNA injected was kept under
50 ng/oocyte so that the oocyte translation system was not over-
whelmed. Unless stated otherwise, the oocytes will be assayed
2 days (36–48 h) after injection by radiotracer 22Na+ uptake or by
extracting proteins for Western blot analysis. NCC activity was as-
sessed by 22Na+ tracer uptake in isotonic uptake solution as re-
ported [11,12,17], with or without overnight Cl free treatment.
After uptake, oocytes were washed six times and then lysed in
10% SDS solution. Radioactivity of each oocyte was determined
using a scintillation counter. Statistical signiﬁcance is deﬁned as
P < 0.05 by Student’s t-test or Mann–Whitney Rank Sum Test using
SigmaPlot 10 (Systat Software, Inc., Chicago, IL).
3. Results and discussion
3.1. KLHL3 abolishes the effect of WNK4 on NCC by decreasing WNK4
protein abundance
KLHL3 decreases the plasma membrane level of NCC in HEK293
cells [19]. However, it was unclear whether NCC or a regulator of
NCC is a substrate of the ubiquitin E3 ligase complex with KLHL3
as the substrate adaptor. We examined this further using X. laevis
oocyte system that is conventionally utilized to evaluate NCC
activity. Without Cl depletion treatment, WNK4 exerted a positive
effect on NCC-mediated Na+ uptake in X. laevis oocytes (Fig. S1A).
This effect was abolished when oocytes were treated in a Cl free
medium overnight before uptake experiments (Fig. S1A). Consis-
tent with previous report [15], the level of phosphorylated serine
325 (p-S325) in OSR1 was increased by WNK4 without Cl deple-
tion; it was also elevated by Cl depletion in the absence of exog-
enous WNK4 (Fig. S1B). Thus, the WNK4–OSR1/SPAK–NCC
pathway might have been largely masked by Cl depletion. How-
ever, the level of p-S325 did not entirely correlate with the activity
of NCC (Fig. S1), suggesting the pathway activated by WNK4 and
that activated by Cl depletion may overlap but may not be iden-
tical. We chose to examine the effect of KLHL3 on the WNK4–
OSR1–NCC pathway without Cl depletion treatment so that the
positive effect of WNK4 on NCC could be observed.
When KLHL3 was co-expressed with NCC or with both NCC and
WNK4, the activity of NCC and the positive effect of WNK4 on NCC
were both inhibited (Fig. 1A). Because KLHL proteins serve as sub-
strate adaptors in CUL3-RING ubiquitin E3 ligase complexes
[21,22], we reasoned that it is most likely KLHL3 is an adaptor
for NCC or its regulator. We thus tested the effects of KLHL3 on
the protein abundance of NCC and its regulators WNK4 and
OSR1. An HA- or FLAG-tag was inserted in the NH2-terminus of
each of the proteins for assessing their abundance with Western
Fig. 1. KLHL3 inhibited the effect of WNK4 on NCC-mediated Na+ uptake by decreasing WNK4 protein abundance. (A) KLHL3 inhibited NCC-mediated Na+ uptake and blocked
the effect of WNK4 on NCC when expressed in X. laevis oocytes. Data from 33 to 45 oocytes/group from 4 independent experiments are shown as means ± S.E. ⁄ indicates
P < 0.05; NS, not signiﬁcant (P > 0.05). (B) The effects of KLHL3 on the protein abundance of NCC, WNK4, and OSR1. HA-tagged NCC, WNK4, or OSR1 was expressed with HA- or
FLAG-tagged KLHL3 in X. laevis oocytes and their protein abundance and that of phosphorylated serine 325 (p-S325) of OSR1 and b-actin (loading control) were assessed by
Western blot analysis 2 days later. The levels of WNK4 and p-S325, but not those of NCC and total OSR1, were reduced by KLHL3.
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reduced by KLHL3 (Fig. 1B). In contrast, WNK4 was not detectable
and p-S325 in OSR1 was lowered in the presence of KLHL3
(Fig. 1B). Similarly, KLHL3 also inhibited the positive regulation
of WNK4 on NKCC2 without reducing the protein abundance of
NKCC2 (data not shown).
These results suggest that KLHL3 is the substrate adaptor for
WNK4, not for NCC or OSR1, in a ubiquitin E3 ligase complex. This
does not exclude the possibility that KLHL3 regulates NCC in a way
unrelated to its degradation or KLHL3 regulates other regulators of
NCC because KLHL3 inhibited NCC activity without exogenous
WNK4 (Fig. 1A). However, if the basal activity of NCC depends on
endogenous WNK4, which has been shown to be expressed in X.
laevis oocytes [25], the effect of KLHL3 on NCC could be due to
the elimination of endogenous WNK4 by KLHL3. The reduction of
phosphorylated and total NCC proteins in WNK4 knockout mice
indicates that WNK4 is essential to NCC phosphorylation and sta-
bility [10]. Phosphorylation of NCC via the WNK4–SPAK/OSR1
pathway may increase cell surface level of NCC and prevent NCC
degradation [26]. We did not observe a signiﬁcant effect of KLHL3
on NCC protein abundance likely due to the absence of signiﬁcant
level of the ubiquitin E3 ligase for NCC degradation in oocytes.
3.2. Cullin 3 is involved in the regulation of WNK4 stability
CUL3 connects substrate adaptor and RING-box 1 ubiquitin li-
gase E3 in ubiquitin E3 ligase complexes [20]. Unlike the KLHL3,
the effect of CUL3 on NCC-mediated Na+ uptake was modest
(Fig. 2A). Based on the Expressed Sequence Tag (EST) database, cul-
lin 3 is expressed in X. laevis oocytes. Therefore, it is likely that
KLHL3 is the rate-limiting factor. As shown in Fig. 2B, HA-WNK4
protein was at a steady state without HA-KLHL3 12 h after injec-
tion. However, only 4 h after injection of HA-KLHL3, HA-WNK4
protein was largely degraded. The NH2-terminal region of CUL3
interacts with substrate adaptor and thus has a dominant-negative
effect on CUL3 [27]. When the NH2-terminal 400 amino-acid seg-
ment of CUL3 (CUL3 1–400) was expressed, the effect of KLHL3
was partially blocked. In some (but not all) batches of oocytes,
injection of HA-CUL 1–400 also increased the level of HA-WNK4
in a dose-dependent manner (Fig. 2C). This effect may depend on
the expression of endogenous KLHL3, which is likely low and var-
iable. These results with dominant-negative CUL3 support a role of
CUL3 in regulating WNK4 stability. GST-CUL3 and GST-WNK4 but
not GST alone (control) pulled down HA-KLHL3 expressed in oo-
cytes (Fig. 2D). This indicates that KLHL3 has the ability to form
a protein complex with both CUL3 and WNK4.3.3. KLHL3 increases the ubiquitination and degradation of WNK4
To determine the effect of KLHL3 on the ubiquitination of
WNK4, we detected the ubiquitination of WNK4 using the ap-
proach we used previously [24]. We co-injected HA-ubiquitin
and GST–WNK4 or GST (as control), and 1 day later, FLAG-KLHL3
was injected. GST–WNK4 proteins were undetectable in the sam-
ples pulled down by glutathione beads 3 and 6 h after FLAG-KLHL3
injection. Meanwhile, high molecular weight smears became
detectable by HA antibody (Fig. 3A). Such smears were not
detected in the control group that expressed GST instead of
GST–WNK4 (Fig. 3B). The disappearance of GST–WNK4 band and
the concomitant appearance of the smear higher than
GST–WNK4 indicate that the smear represents poly-HA-ubiquiti-
nated GST–WNK4. Because the heterogeneously polyubiquinated
WNK4 molecules contained multiple HA-tags but only one GST-
tag, they were detectable by HA antibody but not by GST antibody.
This result indicates that KLHL3 promotes WNK4 polyubiquitina-
tion, which marks WNK4 for proteolysis.
3.4. PHAII mutations in KLHL3 decrease its ability to reduce WNK4
protein abundance
If WNK4 is the true target of KLHL3 and the regulation of WNK4
stability by KLHL3 is essential to the pathogenesis of PHAII, one
would expect that PHAII mutations in KLHL3 will result in
alterations in WNK4 protein abundance. KLHL3 contains BTB
(Bric-a-brac, Tramtrack, Broad-complex) and BACK (BTB and
COOH-terminal Kelch) domains in the NH2-terminal region and
six kelch repeats in the COOH-terminal region (Fig. 4A). The BTB
and BACK domains of KLHL7 are involved in the interaction with
CUL3 [22]. The kelch repeats form b-propellers for substrate recog-
nition [28]. We tested ﬁve representative PHAII mutations, includ-
ing A77E in the BTB domain, C164F in the BACK domain, and
Q309R, L387P, and R528C in kelch repeats (Fig. 4A). After HA-
WNK4 was co-expressed with the wild-type or individual KLHL3
mutant for 36 h, HA-WNK4 was undetectable in the presence of
wild-type KLHL3; however, it was detectable in the presence of
each of the KLHL3 mutants tested (Fig. 4B). The A77E mutant in
the BTB domain completely abolished the negative effect of KLHL3
on HA-WNK4. The C164F mutation in the BACK domain also exhib-
ited a strong effect. The mutations in the kelch repeats disrupted
the suppression of HA-WNK4 to lesser extents. These results sug-
gest that mutations in different functional domains of KLHL3 im-
pair its function differently. Wild-type KLHL3 eliminated WNK4
protein in 3–6 h (Fig. 3), whereas the least effective R528C mutant
Fig. 2. The role of CUL3 in WNK4 stability. (A) HA-CUL3 moderately inhibited Na+ uptake of HA–NCC without reducing its protein abundance. Data from 33 to 35 oocytes/
group from 4 independent experiments are shown as means ± S.E. ⁄ indicates P < 0.05. (B) Left panel, oocytes were injected with HA-WNK4 cRNA and 12 h later, HA-KLHL3
cRNA (or water in the control group) was injected. After 4 h, oocytes were treated with protein synthesis blocker cycloheximide (CHX) at 100 lg/ml. Proteins of oocytes were
extracted at 12, 16, and 20 h after injection of HA-WNK4 cRNA. Upper panel shows the time points of experiment, and lower panel shows the level of HA-WNK4 and HA-
KLHL3 at these points. Right panel, co-injection of HA-CUL3 1–400 partially blocked HA-KLHL3 induced reduction in HA-WNK4 abundance. (C) HA-CUL3 1–400 dose–
dependently increases the level of HA-WNK4 protein in some batch of oocytes. (D) When the lysate of oocytes expressing GST-CUL3, GST-WNK4, or GST alone was mixed with
lysate of oocytes expressing HA-KLHL3, HA-KLHL3 was pulled down by either GST-CUL3 or GST-WNK4 but not by GST alone.
Fig. 3. KLHL3 increased WNK4 ubiquitination. cRNAs for HA-ubiquitin and GST-WNK4 (or GST as control) were injected into oocytes. After 12 h, oocytes were injected with
cRNA for FLAG-KLHL3 or water as control. GST-WNK4 (A) and GST (B) proteins were pulled down at 0, 3, and 6 h after injection of FLAG-KLHL3 or water and the ubiquitinated
proteins were detected by HA-antibody (upper panel). The levels of GST-WNK4 (or GST) in pulled down samples and FLAG-KLHL3 in oocytes lysate were detected with GST
antibody and FLAG antibody, respectively.
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PHAII mutations drastically decreased the ability of KLHL3 in
reducing WNK4 protein abundance.
In order to examine to what extent the remaining WNK4 level
under the inﬂuence of KLHL3 mutants promotes NCC activation,
we evaluated NCC-mediated Na+ uptake in the presence of
WNK4 and individual KLHL3 mutants in oocytes. The level of
NCC-mediated Na+ uptake in the presence of each of the ﬁve
KLHL3 mutants was signiﬁcantly increased compared to that in
the presence of wild-type KLHL3 (Fig. 4C). Intriguingly, the
NCC-mediated Na+ uptake was relatively low even though theWNK4 abundance was relatively high in the presence of A77E
or C164F mutant (Fig. 4B and C). The reason for this discrepancy
is unclear. Unlike PHAII mutations in the kelch repeats that likely
disrupt the interaction with WNK4, A77E and C164F mutations in
the BTB-BACK domain may perturb the interaction with CUL3
[22]. Thus, these two mutations may interfere with all substrates
of KLHL3-CUL3 ubiquitin E3 ligase complex. If one of the sub-
strates is an unidentiﬁed ‘‘NCC inhibitor’’ in oocytes, the scenario
of lowered NCC activity in the presence of higher level of WNK4
could occur due to the enhanced inhibition of NCC by the
inhibitor.
Fig. 4. PHAII-causing mutants of KLHL3 were less effective in reducing WNK4
protein abundance in X. laevis oocytes. (A) Representative PHAII-causing mutations
examined in this study. (B) HA-WNK4 protein abundance assessed by Western blot
analysis in the presence or absence of wild-type (WT) or mutants of HA-KLHL3. HA
antibody detected both HA-WNK4 and HA-KLHL3 at different molecular weights. A
summary of the band intensity of HA-WNK4 from three experiments is shown in
the upper panel. (C) NCC-mediated Na+ uptake in the presence of WNK4 and WT or
mutant HA-KLHL3. Similar to the Western blot experiments in (B), uptake
experiments were performed at 36 h after cRNA injection. Data from 18 oocytes/
group derived from 2 frogs are shown as means ± S.E. ⁄ indicates P < 0.05 vs. WT HA-
KLHL3 group; # indicates P < 0.05 vs. the group without HA-KLHL3.
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E3 ligase complex with KLHL3 as a substrate adaptor. This ubiqui-
tin E3 ligase complex speciﬁcally decreases the protein abundance
of WNK4 without decreasing that of OSR1 and NCC. KLHL3 is abun-
dantly expressed in the DCT and to a much lesser extent in the con-
necting tubule and collecting duct [18,19]. Thus, PHAII mutations
in KLHL3 are expected to increase WNK4 abundance mostly in
the DCT, where NCC is expressed. Thus, PHAII mutation in KLHL3
is not equivalent to the overall overexpression of WNK4 in the
WNK4 transgenic mouse model reported previously [8].
Point mutations in either WNK4 or KLHL3 may result in PHAII
[3,18,19]. PHAII mutations in WNK4 disrupt the regulation of
WNK4 kinase activity and lock WNK4 at an activated state equiv-
alent to that stimulated by angiotensin II and aldosterone[4,5,17]. The total activity of WNK4 depends not only on its speciﬁc
activity, but also on the total amount of WNK4 protein. The results
of this study suggest that protein abundance of WNK4 is controlled
by KLHL3. PHAII mutations in KLHL3 lead to elevated WNK4 pro-
tein abundance and in turn, elevated kinase activity. Thus, PHAII
mutations in bothWNK4 and KLHL3 affect the same pathway. Sim-
ilar conclusions were reached in two independent studies pub-
lished during the revision of this manuscript [29,30]. While we
emphasized the effect of KLHL3 on WNK4 in the context of NCC
function and the impacts of PHAII mutations of KLHL3 on WNK4
protein abundance, these studies indicate that KLHL3 is also a sub-
strate adaptor for WNK1 [29], and PHAII mutations in the acidic
motif of WNK4 affect the regulation of WNK4 by KLHL3 [29,30].
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